Chlamydia pneumoniae infections in asthma: Clinical implications

American Journal of Respiratory Medicine

Volumn 2, Issue 1, 2003, Pages 31-38

  Gencay, Mesut ^a,b   Roth, Michael ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIUM ANTIBODY; MACROLIDE;

ADULTHOOD; ANTIBODY DETECTION; ASTHMA; CELL FUNCTION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DRUG CHOICE; EPIDEMIOLOGICAL DATA; ERADICATION THERAPY; GEOGRAPHIC DISTRIBUTION; HOST CELL; HUMAN; INFECTION RATE; INFECTION SENSITIVITY; INFLAMMATORY DISEASE; LABORATORY DIAGNOSIS; LONG TERM CARE; NONHUMAN; PATHOGENESIS; PATHOLOGY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEASONAL VARIATION; SEROPREVALENCE; TREATMENT OUTCOME; TROPICS;

EID: 0041854733     PISSN: 11756365     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03256637     Document Type: Review

References (117)

1. Laitinen LA, Laitinen L, Altraja A, et al. Bronchial biopsy findings in intermittent or "early" asthma. J Allergy Clin Immunol 1996; 98: S3-6
2. Vignola AM, Chanez P, Campbell AM, et al. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 1998; 157: 403-9
3. Mauad T, Xavier ACG, Saldiva PHN, et al. Elastosis and fragmentation of fibers of the elastic system in fatal asthma. Am J Respir Crit Care Med 1999; 160: 968-75
4. Daser A, Daheshia M, De Sanctis GT. Genetics of allergen-induced asthma. J Allergy Clin Immunol 2001; 108: 167-74
5. Chapman MD, Tsay A, Vailes LD. Home allergen monitoring and control: improving clinical practice and patient benefits. Allergy 2001; 56: 604-10
6. Bornehag CG, Blomquist G, Gyntclberg F, et al. Dampness in buildings and health: Nordic interdisciplinary review of the scientific evidence on associations between exposure to "dampness" in buildings and health effects (NORDDAMP). Indoor Air 2001; 11: 72-86
7. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001; 86: 494-507
8. Martin RJ, Kraft M, Chu HW, et al. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001; 107: 595-601
9. Esposito S, Blasi F, Arosio C, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J 2000; 16: 1142-6
10. Daian CM, Wolff AH, Bielory L. The role of atypical organisms in asthma. Allergy Asthma Proc 2000; 21: 107-11
11. Freymuth F, Vabret A, Brouard J, et al. Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol 1999; 13: 131-9
12. Micillo E, Bianco A, D'Auria D, et al. Respiratory infections and asthma. Allergy 2000; 55 Suppl. 61: 42-5
13. Teichtahl H, Buckmaster N, Pertnikovs E. The incidence ot respiratory tract infection in adults requiring hospitalisation for asthma. Chest 1997; 112: 591-6
14. Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections. Lancet Infect Dis 2001: 1: 334-44
15. Mygind N. The common cold as a trigger of asthma. Monaldi Arch Chest Dis 2000; 55: 478-83
16. Marin J, Jeler-Kacar D, Levstek V, et al. Persistence of viruses in upper respiratory tract of children with asthma. J Infect 2000; 41: 69-72
17. Grayston JT, Kuo CC, Wang SP, et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986; 315: 161-8
18. Hahn DL, Azenabor AA, Beatty WL, et al. Chlamydia pneumoniae as a respiratory pathogen. Front Biosci 2002; 7: E66-76
19. Schachter J. Chlamydial infections (part I). N Engl J Med 1978; 298: 428-35
20. Zhang JP, Stephens RS. Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell 1992: 69: 861-9
21. Chen JC, Stephens RS. Trachoma and LGV biovars of Chlamydia trachomatis share the same glycosaminoglycan-dependent mechanism for infection of eukaryotic cells. Mol Microbiol 1994; 11: 501-7
22. Eckman MR, Leinonen M, Syrjälä H. et al. Evaluation of serological methods in the diagnosis of C. pneumoniae during an epidemic in Finland. Eur J Clin Microbiol 1993; 12: 756-60
23. Saikku P. Chlamydial serology in respiratory tract infections. In: Stary A, editor. Proceedings, third meeting of the European Society for Chlamydia Research. Bologna: Società Editrice Esculapio, 1996: 353
24. Hindiyeh M, Carroll KC. Laboratory diagnosis of atypical pneumonia. Semin Respir Infect 2000; 15: 101-13
25. Verkooyen RP, Hazenberg MA, van Haaswn GH, et al. Age related interferences with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor. J Clin Microbiol 1992: 30: 1289-90
26. Grayston JT, Aldous MB, Easton A, et al. Evidence that C. pneumoniae causes pneumonia and bronchitis. J Infect Dis 1993; 168: 1231-5
27. File TM, Bartlett JG, Cassell GH, et al. The importance of Chlamydia pneumoniae as a pathogen: the 1996 consensus conference on C. pneumoniae infections. Infect Dis Clin Pract 1997; 6 Suppl. 2: S28-31
28. Lorenz J. Clinical efficacy of new antibacterial therapies in at risk populations (review). J Infect 2002: 44 Suppl. A: 25-30
29. Gaydos CA, Roblin PM, Hammerschlag MR, et al. Diagnostic utility of PCR- enzyme immunoassay, culture, and serology for detection of C. pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 1994; 32: 903-5
30. Ramirez JA, Ahkee S, Tolentino A, et al. Diagnosis of Legionella pneumophilia, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen. Diagn Microbiol Infect Dis 1996; 24: 7-14
31. Petitjean J, Vincent F, Fretigny M, et al. Comparison of two serological methods and a polymerase chain reaction-enzyme immunoassay for the diagnosis of acute respiratory infections with Chlamydia pneumoniae in adults. J Med Microbiol 1998; 47: 615-21
32. Dowell SF, Peeling RW, Boman J, et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33: 492-503
33. Hammerschlag MR. Chlamydia pneumoniae and the lung. Eur Respir J 2000; 16: 1001-7
34. Zawadzke L, Thanassi J, Pucci M, et al. 100th American society for microbiology annual meeting. Expert Opin Investig Drugs 2000; 9: 1907-22
35. Vincent F, Petitjean J, Filmont JE, et al. Acute respiratory Chlamydia pneumoniae infections in adults: value of direct gene amplification-diagnosis. Rev Mal Respir 1999; 16: 1131-7
36. Saikku P, Leinonen M, Mattila M, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with coronary heart disease and acute myocardial infarction. Lancet 1988; II: 983-6
37. Katsenis C, Kouskouni E, Kolokotronis L, et al. The significance of Chlamydia pneumoniae in symptomatic carotid stenosis. Angiology 2001; 52: 615-9
38. Vink A, Pasterkamp G, Poppen M, et al. The adventitia of atherosclerotic coronary arteries frequently contains Chlamydia pneumoniae. Atherosclerosis 2001; 157: 117-22
39. Boman J, Hammerschlag MR. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 2002; 15: 1-20
40. Meijer A, Roholl PJ, Gielis-Proper SK, et al. Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions. J Clin Pathol 2000; 53: 911-6
41. Koskiniemi M, Gencay M, Salonen O, et al. Chlamydia pneumoniae associated with central nervous system infections. Eur Neurol 1996; 36: 160-3
42. Koyi H, Branden E, Gnarpe J, et al. Chlamydia pneumoniae maybe associated with lung cancer: preliminary report on a seroepidemiological study. APMIS 1999; 107: 828-32
43. Jackson LA, Wang SP, Nazar-Stewart V, et al. Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 1263-6
44. Koyi H, Branden E, Gnarpe J, et al. An association between chronic infection with Chlamydia pneumoniae and lung cancer: a prospective 2-year Study. APMIS 2001: 109: 572-80
45. Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect 1992; 25: 27-34
46. Laurila AL, Von Hertzen L, Saikku P. Chlamydia pneumoniae and chronic lung diseases. Scand J Infect Dis 1997; 104: 34-6
47. Einarsson S, Sigurdsson HK, Magnusdomir SD, et al. Age specific prevalence of antibodies against Chlamydia pneumoniae in Iceland. Scand J Infect Dis 1994; 26: 393-7
48. Karvonen M, Tuomilehto J, Naukkarinen A, et al. The prevalence and regional distribution of antibodies against Chlamydia pneumoniae (strain TWAR) in Finland in 1958. Int J Epidemiol 1992; 21: 391-8
49. Karvonen M, Tuomiletho J, Pitkaniemi J. et al. Chlamydia pneumoniae antibody prevalence in South-Western and Eastern Finland in 1983 and 1987. Int J Epidemiol 1994; 23: 176-83
50. Birkbaek NJ, Jensen JS, Seefeldt T, et al. Chlamydia pneumoniae infection in adults with chronic cough compared with healthy blood donors. Eur Respir J 2000; 16: 108-11
51. Freidank HM, Brauer D. Prevalence of antibodies to Chlamydia pneumoniae TWAR in a group of German medical students. J Infect 1993; 27: 89-93
52. Van der Abeele AM, Van Renterghem L, Willems K, et al. Prevalence of antibodies to Chlamydia pneumoniae in a Belgian population. J Infect Dis 1992; 25 Suppl. 1: 87-90
53. Gencay M, Rüdiger JJ, Tamm M, et al. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med 2001; 163: 1097-100
54. Marton A, Karoly A, Szalka A. Prevalence of Chlamydia pneumoniae antibodies in Hungary. Eur J Clin Microbiol Infect 1992; 11: 139-42
55. Gencay M, Dereli D, Ertem E, et al. Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and health subjects in Izmir, Turkey. Eur J Epidemiol 1998; 14: 505-9
56. Miyashita N, Niki Y, Nakajama M, et al. Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest 2001; 119: 1416-9
57. Wang SP, Liu YC, Cheng DL, et al. Seroprevalence of Chlamydia pneumoniae in Taiwan. Scand J Infect Dis 1993; 25: 565-8
58. Suttithawil W, Wangroongsarb P, Naigowit P, et al. Chlamydophila (Chlamydia) pneumoniae as a cause of community-acquired pneumonia in Thailand. J Med Assoc Thai 2001; 84: 430-7
59. San Joaquin VH, Herrin JR, Hautala JM. Chlamydial pneumonia of infancy: further clinical observations. Clin Pediatr (Phila) 1980; 19: 109-12
60. Roldaan AC, Masural N. Viral respiratory infections in asthmatic children staying in a mountain resort. Eur J Respir Dis 1982; 63: 140-50
61. Weiss SG, Newcomb RW, Beem MO. Pulmonary assessment of children after chlamydial pneumonia of infancy. J Pediatr 1986; 108: 659-64
62. Hammerschlag MR. Atypical pneumonias in children. Adv Pediatr Infect Dis 1995: 10: 1-39
63. Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994; 148: 727-32
64. Emre U, Sokolovskaya N, Roblin PM, et al. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis 1995; 172: 265-7
65. Cunningham AF, Johnston SL, Julious SA, et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J 1998; 11: 345-9
66. Martinez Tagle M, Kogan R, Rojas P, et al. Diagnosis of Chlamydia pneumoniae in community-acquired pneumonia in children in Chile. Acta Paediatr 2000; 89: 650-3
67. Esposito S, Principi N. Asthma in children: are chlamydia or mycoplasma involved? Paediatr Drugs 2001; 3: 159-68
68. Shamssain MH, Shamsian N. Prevalence and severity of asthma, rhinitis, and atopic eczema in 13-14 year-old schoolchildren from the northeast of England. Ann Allergy Asthma Immunol 2001; 86: 428-32
69. Weiland SK, von Mutius E, Hirsch T, et al. Prevalence of respiratory and atopic disorders among children in the east and west of Germany five years after unification. Eur Respir J 1999; 14: 862-70
70. Lee SI, Shin MH, Lee HB, et al. Prevalence of symptoms of asthma and other allergic diseases in Korean children: a nationwide questionnaire. J Korean Med Sci 2001; 16: 155-64
71. Trabukultivakorn M. Prevalence of asthma, rhinitis, and eczema in northern Thai children from Chiang Mai (International Study of Asthma and Allergies in Childhood, ISAAC). Asian Pac J Allergy Immunol 1999; 17: 243-8
72. Asher MI, Barry D, Clayton T, et al. The burden of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema in children and adolescents in six New Zealand centres: ISAAC phase one. N Z Med J 2001; 114: 114-20
73. Behbehani NA, Abal A, Syabbalo NC, et al. Prevalence of asthma, allergic rhinitis, and eczema in 13- to 14 year old children in Kuwait: an ISAAC study. Ann Allergy Asthma Immunol. 2000: 85: 58-63
74. Mallol J, Solé D, Asher I, et al. Prevalence of asthma symptoms in Latin America: the international study of asthma and allergies in childhood (ISAAC). Pediatr Pulmonol 2000; 30: 439-44
75. Mills GD, Lindeman JA, Fawcett JP, et al. Chlamydia pneumoniae serological status is not associated with asthma in children or young adults. Int J Epidemiol 2000; 29: 280-4
76. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991; 266: 225-30
77. Hahn DL. Chlamydia pneumoniae infection and asthma. Lancet 1992; 339: 1173-4
78. Puolakkainen M, Ukkonen P, Saikku P. The seroepidemiology of Chlamydia in Finland over the period 1971-1987. Epidemiol Infect 1989; 102: 287-95
79. Klaukka T, Peura S, Martikainen J. Why has the utilisation of antiasthmatics increased in Finland? J Clin Epidemiol 1991; 44: 859-63
80. Grayston JT, Campbell LA, Kuo C-C, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161: 618-25
81. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992; 15: 757-61
82. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307: 982-6
83. Pietrzak MP. Aviators have been grounded due to the development of asthma [letter]. Aviat Space Environ Med 1993; 64: 254
84. Hahn DL, Golubjatnikov R. Asthma and chlamydial infection: a case series. J Fam Pract 1994; 38: 589-95
85. Hahn DL. Infection as a cause of asthma [letter]. Ann Allergy 1994; 73: 276
86. Hahn DL. Treatment of Chlamydia pneumoniae infection in adult asthma: a before-after trial. J Fam Pract 1995; 41: 345-51
87. Hahn DL, Anttila T, Saikku P. Association of Chlamydia pneumoniae IgA anti-bodies with recently symptomatic asthma. Epidemiol Infect 1996; 117: 513-7
88. Hahn DL, Bukstein D, Luskin A, et al. Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. Ann Allergy Asthma Immunol 1998; 80: 45-9
89. Hahn DL, McDonald R. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma? Ann Allergy Asthma Immunol 1998; 81: 339-44
90. Hahn DL. Chlamydia pneumoniae antibodies and adult-onset asthma [letter]. J Allergy Clin Immunol 2000: 106: 404
91. Hahn DL, Peeling RW, Dillon E, et al. Serologic markers for Chlamydia pneumoniae in asthma. Ann Allergy Asthma Immunol 2000; 84: 227-33
92. Bjornsson E, Hjelm E, Janson C, et al. Serology of chlamydia in relation to asthma and bronchial hyperresponsiveness. Scand J Infect Dis 1996; 28: 63-9
93. Von Hertzen L, Toyryla M, Gimishanov A, et al. Asthma, atopy and Chlamydia pneumoniae antibodies in adults. Clin Exp Allergy 1999; 29: 522-8
94. Miyashita N, Kubota Y, Nakaijama M, et al. Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol 1998; 80: 405-9
95. Cook PJ, Davies P, Tunnicliffe W, et al. Chlamydia pneumoniae and asthma. Thorax 1998; 53: 254-9
96. Black PN, Scicchitano R, Jenkins CR, et al. Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma. Eur Respir J 2000; 15: 254-9
97. ten Brinkc A, van Dissel JT, Sterk PJ, et al. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol 2001; 107: 449-54
98. Von HL, Vasankari T, Liioppo K, et al. Chlamydia pneumoniae and severity of asthma. Scand J Infect Dis 2002; 34: 22-7
99. Von HL. Role of persistent infection in the control and severity of asthma focus on Chlamydia pneumoniae. Eur Respir J 2002; 19: 546-56
100. Kol A, Lichtman AH, Finberg RW, et al. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol 2000; 164: 13-7
101. Huittinen T, Hahn D, Anttila T, et al. Host immune response to Chlamydia pneumoniae heat shock protein 60 is associated with asthma. Eur Respir J 2001; 17: 1078-82
102. Larsen FO, Norn S, Mordhorst CH, et al. Chlamydia pneumoniae and possible relationship to asthma: serum immunoglobulins and histamine release in patients and controls. APMIS 1998; 106: 928-34
103. Routes JM, Nelson HS, Noda JA, et al. Lack of correlation between Chlamydia pneumoniae antibody titers and adult-onset asthma. J Allergy Clin Immunol 2000; 105: 391-2
104. Blasi F,. Legnani D, Lombardo VM, et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 1993; 6: 19-22
105. Blasi F, Consentini R, Legnais D, et al. Incidence of community-acquired pneumonia caused by Chlamydia pneumoniae in Italian patients. Eur J Clin Microbiol Infect Dis 1993: 12: 696-9
106. Block S, Hedrick J, Hammerschlag MR, et al. Comparative safety and efficacy of clarithromycin and erythromycin ethylsuccinate suspension in the treatment of children with community-acquired pneumonia. Pediatr Infect Dis 1995; 14: 471-7
107. Hammerschlag MR, Chirgwin K, Roblin PM, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infest Dis 1992; 14: 178-82
108. File TM, Segeti J, Dunbar L, et al. A multicenter randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin verses ceftriaxone and/or cefuroxime axetil in the treatment of adults with community acquired pneumonia. Antimicrob Agents Chemother 1997; 41: 1965-72
109. Schönwald S, Kuzman I, Oreskovic K, et al. Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome: a randomized study. Infection 1999; 27: 198-202
110. Vergis EN, Indorf A, File TM, et al. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med 2000; 160: 1294-300
111. Hammerschlag MR, Roblin PM. Microbiologic efficacy of moxifloxacin for the treatment of community acquired pneumonia due to Chlamydia pneumoniae. Int J Antimicrob Agents 2000; 15: 149-52
112. Numazaki K, Sakamoto Y, Umetsu M, et al. Therapeutic effect of clarithromycin for respiratory-tract infections in children caused by Chlamydia pneumoniae. Int J Antimicrob Agents 2000; 13: 219-22
113. Gray GC, Witucki PJ. Gould MT, et al. Randomized, placebo-controlled clinical trial of oral azithromycin prophylaxis against respiratory infections in a high-risk, young adult population. Clin Infect Dis 2001; 33: 983-9
114. Johnston SL. Is Chlamydia pneumomae important in asthma?: the first controlled trial of therapy leaves the question unanswered. Am J Respir Crit Care Med 2001; 164: 513-4
115. Richeldi L, Ferrara G, Fabbri LM, et al. Macrolides for chronic asthma (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 4. Oxford: Update Software, 2002: CD002997
116. Black PN, Blasi F, Jenkins CR, et al. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 2001; 164: 536-41
117. Kroegel C, Rodel J, Mock B. Chlamydia pneumoniae, clarithromycin, and severe asthma. Chest 2001; 120: 1035-6